NasdaqCM - Delayed Quote USD
Eyenovia, Inc. (EYEN)
At close: November 7 at 4:00 PM EST
After hours: November 7 at 5:15 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
GANDOLFO JOHN P Chief Financial Officer | Purchase | May 31, 2023 | 8,000 |
GELTZEILER MICHAEL S Director | Stock Award(Grant) | Jun 12, 2024 | 81,295 |
GRANT STUART M Beneficial Owner of more than 10% of a Class of Security | Purchase | Jul 2, 2024 | 6,971,790 |
IANCHULEV TSONTCHO Director | Stock Award(Grant) | Jun 12, 2024 | 1,022,600 |
JACOBSON RACHEL Director | Stock Award(Grant) | Jun 12, 2024 | 104,233 |
KERN BREN Chief Operating Officer | Purchase | May 26, 2023 | 2,500 |
MATHER CHARLES E IV Director | Stock Award(Grant) | Jun 12, 2024 | 156,266 |
PALANKI RAM Director | Stock Award(Grant) | Jun 12, 2024 | 98,909 |
ROWE MICHAEL M Chief Executive Officer | Purchase | Aug 28, 2024 | 109,998 |
STRAHLMAN ELLEN Director | Stock Award(Grant) | Jun 12, 2024 | 136,594 |
Related Tickers
ATRA Atara Biotherapeutics, Inc.
10.10
+0.95%
TPST Tempest Therapeutics, Inc.
1.0600
+1.92%
LYRA Lyra Therapeutics, Inc.
0.2650
-5.32%
RVPH Reviva Pharmaceuticals Holdings, Inc.
0.9409
+0.85%
ENSC Ensysce Biosciences, Inc.
0.6957
+26.42%
TVGN Tevogen Bio Holdings Inc.
1.1400
-12.31%
MIST Milestone Pharmaceuticals Inc.
1.9500
+8.94%
SLS SELLAS Life Sciences Group, Inc.
1.1600
0.00%
IRD Opus Genetics, Inc.
1.0900
-6.84%
UNCY Unicycive Therapeutics, Inc.
0.5698
+13.51%